Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Charlotte M. Mosterd"'
Autor:
Rosalie A. Scholtes, Charlotte M. Mosterd, Anne C. Hesp, Mark M. Smits, Hiddo J. L. Heerspink, Daniël H. van Raalte
Publikováno v:
Scholtes, R A, Mosterd, C M, Hesp, A C, Smits, M M, Heerspink, H J L & van Raalte, D H 2023, ' Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes : A secondary analysis of a randomized crossover trial ', Diabetes, Obesity and Metabolism, vol. 25, no. 1, pp. 198-207 . https://doi.org/10.1111/dom.14864
Diabetes, Obesity and Metabolism, 25(1), 198-207. Wiley
Diabetes, Obesity and Metabolism, 25(1), 198-207. Wiley-Blackwell
Diabetes, Obesity and Metabolism, 25(1), 198-207. Wiley
Diabetes, Obesity and Metabolism, 25(1), 198-207. Wiley-Blackwell
Aim: To study the effects of the sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin, the angiotensin receptor blocker (ARB) losartan, and their combination on blood pressure, while studying the mechanisms potentially involved.Methods: A
Autor:
Rosalie A. Scholtes, Anne C. Hesp, Charlotte M. Mosterd, Frank Geurts, Ewout J. Hoorn, Daan J. Touw, Merle M. Krebber, Jaap A. Joles, Hiddo J.L. Heerspink, Daniël H. van Raalte
Publikováno v:
Circulation, 146(24), 1895-1897. LIPPINCOTT WILLIAMS & WILKINS
Scholtes, R A, Hesp, A C, Mosterd, C M, Geurts, F, Hoorn, E J, Touw, D J, Krebber, M M, Joles, J A, Heerspink, H J L & van Raalte, D H 2022, ' Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination : A Crossover Randomized Trial in People with Type 2 Diabetes ', Circulation, vol. 146, no. 24, pp. 1895-1897 . https://doi.org/10.1161/CIRCULATIONAHA.122.061033
Circulation, 146(24), 1895-1897. Lippincott Williams and Wilkins
Circulation, 146(24), 1895-1897. Lippincott Williams & Wilkins
Scholtes, R A, Hesp, A C, Mosterd, C M, Geurts, F, Hoorn, E J, Touw, D J, Krebber, M M, Joles, J A, Heerspink, H J L & van Raalte, D H 2022, ' Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination : A Crossover Randomized Trial in People with Type 2 Diabetes ', Circulation, vol. 146, no. 24, pp. 1895-1897 . https://doi.org/10.1161/CIRCULATIONAHA.122.061033
Circulation, 146(24), 1895-1897. Lippincott Williams and Wilkins
Circulation, 146(24), 1895-1897. Lippincott Williams & Wilkins
Autor:
Sjoukje van der Hoek, Jeroen V. Koomen, Erik J. M. van Bommel, Charlotte M. Mosterd, Rosalie A. Scholtes, Anne C. Hesp, Jasper Stevens, Daniel H. van Raalte, Hiddo J. L. Heerspink
Publikováno v:
van der Hoek, S, Koomen, J V, van Bommel, E J M, Mosterd, C M, Scholtes, R A, Hesp, A C, Stevens, J, van Raalte, D H & Heerspink, H J L 2023, ' Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes ', Journal of personalized medicine, vol. 13, no. 5, 747 . https://doi.org/10.3390/jpm13050747
Journal of personalized medicine, 13(5):747. MDPI AG
Journal of Personalized Medicine; Volume 13; Issue 5; Pages: 747
Journal of personalized medicine, 13(5):747. Multidisciplinary Digital Publishing Institute (MDPI)
Journal of personalized medicine, 13(5):747. MDPI AG
Journal of Personalized Medicine; Volume 13; Issue 5; Pages: 747
Journal of personalized medicine, 13(5):747. Multidisciplinary Digital Publishing Institute (MDPI)
Sodium–glucose cotransporter-2 (SGLT2) inhibitors improve markers for renal and cardiovascular outcomes in patients with and without type 2 diabetes (T2D). To assess whether individual differences in plasma drug exposure can explain inter-individua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59cc313ccc91b0131f6f4169819d073b
https://research.vumc.nl/en/publications/8d520102-a9a8-479e-9f69-9203331b9919
https://research.vumc.nl/en/publications/8d520102-a9a8-479e-9f69-9203331b9919
Autor:
Barbara J.H. Verhaar, Charlotte M. Mosterd, Didier Collard, Henrike Galenkamp, Majon Muller, Elena Rampanelli, Daniël H. van Raalte, Max Nieuwdorp, Bert-Jan H. van den Born
Publikováno v:
Atherosclerosis. Elsevier Ireland Ltd
Verhaar, B J H, Mosterd, C M, Collard, D, Galenkamp, H, Muller, M, Rampanelli, E, van Raalte, D H, Nieuwdorp, M & van den Born, B-J H 2023, ' Sex differences in associations of plasma metabolites with blood pressure and heart rate variability : The HELIUS study ', Atherosclerosis . https://doi.org/10.1016/j.atherosclerosis.2023.05.016
Verhaar, B J H, Mosterd, C M, Collard, D, Galenkamp, H, Muller, M, Rampanelli, E, van Raalte, D H, Nieuwdorp, M & van den Born, B-J H 2023, ' Sex differences in associations of plasma metabolites with blood pressure and heart rate variability : The HELIUS study ', Atherosclerosis . https://doi.org/10.1016/j.atherosclerosis.2023.05.016
Background and aims: Since plasma metabolites can modulate blood pressure (BP) and vary between men and women, we examined sex differences in plasma metabolite profiles associated with BP and sympathicovagal balance. Our secondary aim was to investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30ec12002434acc94ad223cfe78e72eb
https://research.vumc.nl/en/publications/e499db3d-1090-4511-9f8c-caf4e0d524a7
https://research.vumc.nl/en/publications/e499db3d-1090-4511-9f8c-caf4e0d524a7
Autor:
null Rosalie A Scholtes, null Charlotte M. Mosterd, null Anne C Hesp, null Mark M. Smits, null Hiddo JL Heerspink, null Daniël H van Raalte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5d2f263b0127a95a8ab9453a2ce0a6b
https://doi.org/10.1111/dom.14864/v2/response1
https://doi.org/10.1111/dom.14864/v2/response1
Autor:
Charlotte M. Mosterd, Charles F. Hayfron-Benjamin, Bert-Jan H. van den Born, Anke H. Maitland - van der Zee, Charles Agyemang, Daniel H. van Raalte
Publikováno v:
Journal of diabetes and its complications, 36(8):108238. Elsevier Inc.
Journal of Diabetes and its Complications, 36(8):108238. Elsevier Inc.
Mosterd, C M, Hayfron-Benjamin, C F, van den Born, B-J H, Maitland-van der Zee, A H, Agyemang, C & van Raalte, D H 2022, ' Ethnic disparities in the association between low-grade inflammation biomarkers and chronic kidney disease : The HELIUS Cohort Study ', Journal of Diabetes and its Complications, vol. 36, no. 8, 108238 . https://doi.org/10.1016/j.jdiacomp.2022.108238
Journal of Diabetes and its Complications, 36(8):108238. Elsevier Inc.
Mosterd, C M, Hayfron-Benjamin, C F, van den Born, B-J H, Maitland-van der Zee, A H, Agyemang, C & van Raalte, D H 2022, ' Ethnic disparities in the association between low-grade inflammation biomarkers and chronic kidney disease : The HELIUS Cohort Study ', Journal of Diabetes and its Complications, vol. 36, no. 8, 108238 . https://doi.org/10.1016/j.jdiacomp.2022.108238
Aims: Ethnic differences exist in the prevalence and progression of chronic kidney disease (CKD). However, underlying mechanisms remain unclear. It has been proposed that chronic low-grade inflammation plays an important role in CKD pathogenesis. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e7065d096629ab880441670691d4647
https://pure.amc.nl/en/publications/ethnic-disparities-in-the-association-between-lowgrade-inflammation-biomarkers-and-chronic-kidney-disease(3d78f423-2b1f-4e20-9ef6-dd833d53e958).html
https://pure.amc.nl/en/publications/ethnic-disparities-in-the-association-between-lowgrade-inflammation-biomarkers-and-chronic-kidney-disease(3d78f423-2b1f-4e20-9ef6-dd833d53e958).html
Publikováno v:
Mosterd, C M, Bjornstad, P & van Raalte, D H 2020, ' Nephroprotective effects of GLP-1 receptor agonists : where do we stand? ', Journal of Nephrology, vol. 33, no. 5, pp. 965-975 . https://doi.org/10.1007/s40620-020-00738-9
Journal of Nephrology
Journal of Nephrology
Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D). These drugs have potent glucose-lowering actions and, additionally, lower body weight through s
Autor:
Majon Muller, M. Nieuwdorp, B Verhaar, Didier Collard, Charlotte M. Mosterd, D.H. van Raalte, B.J.H. van den Born, Henrike Galenkamp
Publikováno v:
European Heart Journal. 42
Background Blood pressure (BP) is regulated by plasma metabolites from different neurohumoral and cardiometabolic systems. Since there are established differences in hypertension pathogenesis and treatment response between ethnicities, we hypothesize
Autor:
Bert-Jan H. van den Born, Didier Collard, Max Nieuwdorp, Henrike Galenkamp, Daniël H. van Raalte, Charlotte M. Mosterd, Charles Agyemang, Marleen Zethof
Publikováno v:
Diabetes care, 44(7), 1692-1698. American Diabetes Association Inc.
OBJECTIVE Studies have shown a disparate association between body composition and the risk of type 2 diabetes. We assessed whether associations between differences in body composition and type 2 diabetes vary among ethnic groups with disparate cardio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee26d11d026f96c2c7a8a1485a014f9
https://pure.amc.nl/en/publications/differences-in-body-composition-convey-a-similar-risk-of-type-2-diabetes-among-different-ethnic-groups-with-disparate-cardiometabolic-riskthe-helius-study(5019924c-6c3f-4eb8-acb7-a3502c00287d).html
https://pure.amc.nl/en/publications/differences-in-body-composition-convey-a-similar-risk-of-type-2-diabetes-among-different-ethnic-groups-with-disparate-cardiometabolic-riskthe-helius-study(5019924c-6c3f-4eb8-acb7-a3502c00287d).html